tirzepatide risks and Cardiovascular Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications for Heart Failure Management Tirzepatide not linked to increased

[8] [9] However, the emergence of GLP-1 receptor agonists (glucagon-like peptide-1 analogues) has opened new therapeutic possibilities

Diabetes Obes Metab 13(4):348356 Gasbjerg LS, Helsted MM, Hartmann B, Jensen MH, Gabe MBN, Sparre-Ulrich AH et al (2019) Separate and combined glucometabolic effects of endogenous glucose-dependent Insulinotropic polypeptide and glucagon-like peptide 1 in healthy individuals

The ideal candidate for Rybelsus is an adult with type 2 diabetes who needs additional blood sugar control or cardiovascular risk reduction, can follow the specific administration requirements, and has been evaluated for contraindications and risk factors

Ferroptosis-related proteins have become attractive targets for many major human diseases that are currently incurable, and some ferroptosis regulators have shown therapeutic effects in clinical trials although further validation of their clinical potential is needed